Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02993263 · ClinicalTrials.gov registry record · NA
Postoperative Acute Myocardial Ischemic Injury
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 323
- Enrollment target
NCT02993263 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 323 participants.
The verdict
NCT02993263, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 323 participants
- Enrollment target
Study Summary
The investigators propose to estimate the sensitivity and specificity of the VectraplexECG System for detecting acute myocardial ischemic injury, including acute myocardial infarctions after major non-cardiac surgery. A 10 second CEB dynamic sequence recording will be obtained immediately after surgery in the post-anesthesia care unit. On the first, second and third post operative morning a 10 second CEB dynamic sequence will be recorded. Blood will be sampled for troponin as well. On the first, second and third post operative afternoons a 10 second CEB dynamic sequence will be recorded. The morning 10 second CEB dynamic sequence and blood draw for troponin will continue as long as the patient remains hospitalized. The afternoon 10 second CEB dynamic sequence will continue as long as the patient remains hospitalized.
Interventions
- DEVICE VectraplexECG System with CEB®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02993263
The ClinicalTrials.gov registry entry for NCT02993263 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VectraplexECG System with CEB® is the first listed.
NCT02993263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02993263 about?
NCT02993263 is a clinical study titled "Postoperative Acute Myocardial Ischemic Injury". The investigators propose to estimate the sensitivity and specificity of the VectraplexECG System for detecting acute myocardial ischemic injury, including acute myocardial infarctions after major non-cardiac surgery. A 10 second CEB dynamic sequence recording will be obtained immediately after sur...
What is the current status of trial NCT02993263?
This trial is currently terminated. It is a NA study. The enrollment target is 323 participants. The study started on 2016-02. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT02993263?
The interventions under investigation include: VectraplexECG System with CEB® (DEVICE).
Who is sponsoring clinical trial NCT02993263?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.